A new study reveals that bariatric surgery results in significantly greater weight loss compared to popular GLP-1 drugs.

4.7%). Patients on continuous GLP-1 therapy for a full year lost more weight, but significantly less than bariatric surgery patients (7% total weight loss). Clinical trials show weight loss ...

Levita Magnetics announced today that it received expanded FDA 510(k) clearance for its MARS (magnetic-assisted robotic ...

BMD and serum calcium levels dropped following bariatric surgery in morbidly obese men and women. Despite the benefits associated with long-term weight loss that are achievable with bariatric ...

New clearance expands clinical use of the disruptive Dynamic Magnetic Positioning™ technology for liver retraction in bariatric and hiatal hernia ...

The use of bariatric surgery for the treatment of morbid obesity has increased dramatically over the past decade, which has raised concerns about safety, efficacy and cost-effectiveness.

Bariatric surgery is an operation that is performed in order to help such individuals lose weight. Evidence suggests that bariatric surgery may lower death rates for patients with severe obesity ...

Gut‑hormone incretins (e.g., GLP‑1 agonists) are the fastest growing segment, forecast to expand at a 33.15% CAGR through ...